59 related articles for article (PubMed ID: 9496265)
1. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components.
Ivanova K; Le Poole IC; Gerzer R; Westerhof W; Das PK
J Pathol; 1997 Dec; 183(4):469-76. PubMed ID: 9496265
[TBL] [Abstract][Full Text] [Related]
2. Non-lesional vitiliginous melanocytes are not characterized by an increased proneness to nitric oxide-induced apoptosis.
Ivanova K; van den Wijngaard R; Gerzer R; Lamers WH; Das PK
Exp Dermatol; 2005 Jun; 14(6):445-53. PubMed ID: 15885080
[TBL] [Abstract][Full Text] [Related]
3. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P
J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761
[TBL] [Abstract][Full Text] [Related]
4. The ectoenzyme gamma-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes.
Henson SE; Nichols TC; Holers VM; Karp DR
J Immunol; 1999 Aug; 163(4):1845-52. PubMed ID: 10438918
[TBL] [Abstract][Full Text] [Related]
5. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix modulates the function of human melanocytes but not melanoma cells.
Ranson M; Posen S; Mason RS
J Cell Physiol; 1988 Aug; 136(2):281-8. PubMed ID: 3137234
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of endothelial cell activation by nitric oxide donors.
Zampolli A; Basta G; Lazzerini G; Feelisch M; De Caterina R
J Pharmacol Exp Ther; 2000 Nov; 295(2):818-23. PubMed ID: 11046123
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide inhibits falcipain, the Plasmodium falciparum trophozoite cysteine protease.
Venturini G; Colasanti M; Salvati L; Gradoni L; Ascenzi P
Biochem Biophys Res Commun; 2000 Jan; 267(1):190-3. PubMed ID: 10623597
[TBL] [Abstract][Full Text] [Related]
9. Rapid and irreversible inactivation of protein tyrosine phosphatases PTP1B, CD45, and LAR by peroxynitrite.
Takakura K; Beckman JS; MacMillan-Crow LA; Crow JP
Arch Biochem Biophys; 1999 Sep; 369(2):197-207. PubMed ID: 10486138
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
[TBL] [Abstract][Full Text] [Related]
11. Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP.
Ivanova K; Lambers B; van den Wijngaard R; Le Poole IC; Grigorieva O; Gerzer R; Das PK
In Vitro Cell Dev Biol Anim; 2008; 44(8-9):385-95. PubMed ID: 18594937
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosoglutathione photolysis as a novel therapy for antifibrosis in filtration surgery.
Tannous M; Hutnik CM; Tingey DP; Mutus B
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):749-55. PubMed ID: 10711690
[TBL] [Abstract][Full Text] [Related]
13. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures.
Nisoli E; Clementi E; Tonello C; Sciorati C; Briscini L; Carruba MO
Br J Pharmacol; 1998 Oct; 125(4):888-94. PubMed ID: 9831929
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of clotting factor XIII activity by nitric oxide.
Catani MV; Bernassola F; Rossi A; Melino G
Biochem Biophys Res Commun; 1998 Aug; 249(1):275-8. PubMed ID: 9705871
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a cyclic GMP-independent mechanism in the anti-platelet action of S-nitrosoglutathione.
Gordge MP; Hothersall JS; Noronha-Dutra AA
Br J Pharmacol; 1998 May; 124(1):141-8. PubMed ID: 9630353
[TBL] [Abstract][Full Text] [Related]
16. Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.
Bérubé M; Talbot M; Collin C; Paquet-Bouchard C; Germain L; Guérin SL; Petitclerc E
Int J Oncol; 2005 Feb; 26(2):405-13. PubMed ID: 15645125
[TBL] [Abstract][Full Text] [Related]
17. Suppression of proliferation of human coronary artery smooth muscle cells by the nitric oxide donor, S-nitrosoglutathione, is cGMP-independent.
Young DV; Serebryanik D; Janero DR; Tam SW
Mol Cell Biol Res Commun; 2000 Jul; 4(1):32-6. PubMed ID: 11152625
[TBL] [Abstract][Full Text] [Related]
18. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
Callsen D; Pfeilschifter J; Brüne B
J Immunol; 1998 Nov; 161(9):4852-8. PubMed ID: 9794418
[TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis by S-nitrosoglutathione and Cu2+ or Ni2+ ion through modulation of bax, bad, and bcl-2 proteins in human colon adenocarcinoma cells.
Ho YS; Liu HL; Duh JS; Chen RJ; Ho WL; Jeng JH; Wang YJ; Lin JK
Mol Carcinog; 1999 Nov; 26(3):201-11. PubMed ID: 10559795
[TBL] [Abstract][Full Text] [Related]
20. The impact of N-nitrosomelatonin as nitric oxide donor in cell culture experiments.
Berchner-Pfannschmidt U; Tug S; Trinidad B; Becker M; Oehme F; Flamme I; Fandrey J; Kirsch M
J Pineal Res; 2008 Nov; 45(4):489-96. PubMed ID: 18673420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
